Skip to main content

The Akkermansia Company is Acquired by Danone

Written by Customer Service on . Posted in Mergers And Acquisitions.

Danone Invests Further in Gut Health and Next-Generation Biotic Science

WILMINGTON, Del., June 25, 2025 (GLOBE NEWSWIRE) — The Akkermansia Company (TAC) today announces that it has been acquired by Danone, a leading global food and beverage company.

TAC’s founding scientists first discovered the biotic strain Akkermansia muciniphila MucT in 2004 and have since developed it using state-of-the-art technology. They clinically demonstrated its power to reinforce the gut barrier, reduce inflammation, and counteract metabolic disorders such as obesity, diabetes and cardiovascular disease. The company has broad patents protecting the use of the Akkermansia species, including the use of the pasteurized version of the strain, MucT, which is its most bio-efficacious form. 

TAC is successfully expanding business into key markets in Europe, North America and Asia.

“We are very excited about becoming part of the Danone family. It provides us with the resources to accelerate global growth of the pasteurized Akkermansia muciniphila MucT strain and develop our brands faster,” said Michael Oredsson, CEO of TAC.

“I am confident that with Danone we will move faster to our goal of giving billions of consumers the opportunity to benefit from improved metabolic health offered by Akkermansia,” said TAC’s Chief Technology Officer, Professor Willem M. DeVos, who discovered Akkermansia and co-founded the company.

About The Akkermansia Company  
An international leader in developing next-generation probiotic and postbiotic supplements, The Akkermansia Company is on a mission to shift the focus of the microbiome health paradigm from symptoms to root cause. Founded by Professor Willem M. de Vos and Professor Patrice D. Cani, the company developed Akkermansia muciniphila MucT®, which plays a major role in helping to maintain a healthy gut microbiome and in maintaining metabolic health. After becoming available in its Belgian home market in 2021, the company is now expanding sales of Akkermansia muciniphila MucT® into key markets in Europe, North America and Asia. Learn more at theakkermansiacompany.com and follow The Akkermansia Company on Facebook and Instagram.

MEDIA CONTACT:
Lisa Lazarczyk, LAZ PR
Tel: 617.838.7327 or lisa@lazpr.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.